课题基金 / 基金详情

Attenuating severe infections in chronic inflammatory diseases through modulation of transforming growth factor-β activity

Attenuating severe infections in chronic inflammatory diseases through modulation of transforming growth factor-β activity
通过调节转化生长因子-β 活性减轻慢性炎症性疾病的严重感染
批准号:
nhmrc : GNT1124485
负责人:
Dr Michael Gantier
金额:
$61.18万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

Dr Michael Gantier的其他基金

相似基金

相关文献

中文摘要
翻译
哮喘和慢性阻塞性肺疾病的特点是转化生长因子β表达增强,伴随着对反复发生的病毒和细菌感染的敏感性。这种感染加剧了这些患者的肺部炎症,通常需要急诊科治疗。该项目旨在阐明转化生长因子β抑制剂在降低慢性阻塞性肺疾病和哮喘患者病毒感染影响方面的治疗潜力。
英文摘要
Asthma and chronic obstructive pulmonary disease (COPD) are characterised by enhanced TGFβ expression, which is accompanied by susceptibility to recurrent viral and bacterial infections. Such infections exacerbate lung inflammation in these patients, generally requiring emergency department treatment. This project proposes to clarify the therapeutic potential of TGFβ inhibitors to reduce the impact of viral infections in patients with COPD and asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Attenuating severe infections in chronic inflammatory diseases through modulation of transforming growth factor-? activity
  • 批准号:
    nhmrc : 1124485
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.8万
  • 财政年份:
    2017
  • 负责人:
    Dr Michael Gantier
  • 依托单位:
Defining a role for TLR7/8 in Helicobacter pylori infection
  • 批准号:
    nhmrc : GNT1081167
  • 项目类别:
    Project Grants
  • 资助金额:
    $54.7万
  • 财政年份:
    2015
  • 负责人:
    Dr Michael Gantier
  • 依托单位:
Targeting small RNA technologies
  • 批准号:
    nhmrc : 1062683
  • 项目类别:
    Project Grants
  • 资助金额:
    $28.9万
  • 财政年份:
    2014
  • 负责人:
    Dr Michael Gantier
  • 依托单位:
microRNA regulation of antiviral responses
  • 批准号:
    nhmrc : 1022144
  • 项目类别:
    Project Grants
  • 资助金额:
    $33.39万
  • 财政年份:
    2012
  • 负责人:
    Dr Michael Gantier
  • 依托单位:
海外基金